Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Binovi Technologies Corp. (BNVIF)
Vancouver, BC, CA
Binovi Technologies Corp. specializes in developing, producing, and marketing innovative hardware and software solutions that address visual and neuro-cognitive processing challenges. These technologies are designed to diagnose, enhance, and remediate visual perception disorders, with the company operating across Canada, the United States, and on an international scale. Its current product portfolio includes Binovi Touch, a dedicated instrument for vision therapy and training; Binovi Pro, a comprehensive platform that empowers professionals and trainers to manage patient and athlete vision training regimens, monitor progress, and assign tailored protocols; Binovi Coach, which provides users with clear multimedia guidance to complete assigned activities; and Binovi Academy, an educational resource hub. Additionally, the company is actively developing Binovi Agile and Binovi Connect, with the latter intended as a web-based video conferencing solution to connect consumers directly with vision care professionals. The company, previously known as Eyecarrot Innovations Corp., officially changed its name to Binovi Technologies Corp. in June 2020. Its headquarters are situated in Vancouver, Canada.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | 0.00% | 0.00% | 0.00% | +400.00% | +400.00% | +400.00% | +126.24% | -87.65% | -99.72% | -99.72% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Healthcare Information Services: +14.2%-74.4% Q1'22: -142.3% (vs Q1'21)
-
EPS growth Medical - Healthcare Information Services: +43.1%+17.4% Q1'22: -119.4% (vs Q1'21)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-7,141.1% Q1'22: +363.6% (vs Q1'21)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-8,745.6% Q1'22: +17,024.1% (vs Q1'21)
-
ROIC Medical - Healthcare Information Services: +5.2%— Q1'22: +2,153.5% (vs Q1'21)
-
Share dilution Medical - Healthcare Information Services: -0.1%+116.0% Q1'22: +58.1% (vs Q1'21)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-0.06× Q1'22: -0.02× (vs Q1'21)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Adam R. Cegielski | Founder & Advisor | 202.8K | male |
| Jatinder Dhaliwal | Chief Executive Officer, Interim Chief Financial Officer & Director | — | male |
| Joe Lia | Director of Video Production & Member of Advisory Board | — | male |
| Robert Sanet | Special Advisor of Behavioral Optometry & Vision Training | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BNVIF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
